Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Amneal Pharmaceuticals
AMRX
$6.15B
| $970K | ﹤0.01% |
487,363
-100,493
| -17% | -$225K |
|
3202
Nano X Imaging
NNOX
$74.2M
| $969K | ﹤0.01% |
131,366
+2,346
| +2% | +$26K |
|
3203
Universal Technical Institute
UTI
$1.4B
| $964K | ﹤0.01% |
143,518
+7,186
| +5% | +$47.5K |
|
3204
Purple Innovation
PRPL
$27.9M
| $964K | ﹤0.01% |
8,049
-154
| -2% | -$16.8K |
|
|
ENFN
3205
DELISTED
Enfusion, Inc.
ENFN
| $963K | ﹤0.01% |
99,572
+28,731
| +41% | +$324K |
|
3206
Astronics
ATRO
$4.57B
| $955K | ﹤0.01% |
111,240
+77
| +0.1% | +$569 |
|
3207
Value Line
VALU
$342M
| $953K | ﹤0.01% |
18,738
-7,104
| -27% | -$401K |
|
3208
Red Violet
RDVT
$1.12B
| $952K | ﹤0.01% |
41,348
+5,973
| +17% | +$122K |
|
3209
WPP
WPP
$5.79B
| $945K | ﹤0.01% |
19,217
+7,315
| +61% | +$348K |
|
3210
Capital Bancorp
CBNK
$616M
| $945K | ﹤0.01% |
40,130
+10,044
| +33% | +$242K |
|
3211
Rhythm Pharmaceuticals
RYTM
$8B
| $940K | ﹤0.01% |
32,283
-7,625
| -19% | -$196K |
|
3212
Oscar Health
OSCR
$10.2B
| $938K | ﹤0.01% |
381,175
+1,208
| +0.3% | +$3.78K |
|
3213
ENI
E
$79.5B
| $937K | ﹤0.01% |
32,705
+900
| +3% | +$24.3K |
|
3214
Ring Energy
REI
$354M
| $936K | ﹤0.01% |
380,453
+45,128
| +13% | +$124K |
|
3215
Pure Cycle
PCYO
$272M
| $930K | ﹤0.01% |
88,766
-12,511
| -12% | -$117K |
|
|
CINC
3216
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $929K | ﹤0.01% |
75,622
+2,759
| +4% | +$65.8K |
|
3217
Park-Ohio Holdings
PKOH
$709M
| $929K | ﹤0.01% |
75,988
+24,561
| +48% | +$306K |
|
3218
Spok Holdings
SPOK
$231M
| $929K | ﹤0.01% |
113,381
-83,607
| -42% | -$679K |
|
3219
WisdomTree International Quality Dividend Growth Fund
IQDG
$731M
| $928K | ﹤0.01% |
30,309
-813
| -3% | -$23.9K |
|
3220
Red River Bancshares
RRBI
$683M
| $927K | ﹤0.01% |
18,156
-3,314
| -15% | -$181K |
|
3221
Timberland Bancorp
TSBK
$358M
| $925K | ﹤0.01% |
27,114
-7,385
| -21% | -$237K |
|
3222
Evolus
EOLS
$534M
| $918K | ﹤0.01% |
122,263
-15
| -0% | -$116 |
|
3223
RGC Resources
RGCO
$227M
| $914K | ﹤0.01% |
41,435
-11,208
| -21% | -$249K |
|
3224
Erasca
ERAS
$6.31B
| $913K | ﹤0.01% |
211,914
-16,430
| -7% | -$111K |
|
3225
Vanguard Consumer Staples ETF
VDC
$8.04B
| $913K | ﹤0.01% |
4,766
-1,184
| -20% | -$223K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.